IL100183A - תכשירים לטיפול בהפרעות השינה המכילים תולדות טריאזול - Google Patents

תכשירים לטיפול בהפרעות השינה המכילים תולדות טריאזול

Info

Publication number
IL100183A
IL100183A IL10018391A IL10018391A IL100183A IL 100183 A IL100183 A IL 100183A IL 10018391 A IL10018391 A IL 10018391A IL 10018391 A IL10018391 A IL 10018391A IL 100183 A IL100183 A IL 100183A
Authority
IL
Israel
Prior art keywords
sleep
rem
composition
disorders
nefazodone
Prior art date
Application number
IL10018391A
Other languages
English (en)
Other versions
IL100183A0 (en
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of IL100183A0 publication Critical patent/IL100183A0/xx
Publication of IL100183A publication Critical patent/IL100183A/he

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL10018391A 1990-12-03 1991-11-28 תכשירים לטיפול בהפרעות השינה המכילים תולדות טריאזול IL100183A (he)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/620,696 US5116852A (en) 1990-12-03 1990-12-03 Treatment of sleep disorders

Publications (2)

Publication Number Publication Date
IL100183A0 IL100183A0 (en) 1992-08-18
IL100183A true IL100183A (he) 1996-12-05

Family

ID=24487000

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10018391A IL100183A (he) 1990-12-03 1991-11-28 תכשירים לטיפול בהפרעות השינה המכילים תולדות טריאזול

Country Status (11)

Country Link
US (1) US5116852A (he)
EP (1) EP0493687B1 (he)
JP (1) JP3062974B2 (he)
AT (1) ATE136777T1 (he)
CA (1) CA2056201A1 (he)
DE (1) DE69118859T2 (he)
DK (1) DK0493687T3 (he)
ES (1) ES2087217T3 (he)
GR (1) GR3019692T3 (he)
IL (1) IL100183A (he)
MX (1) MX9101994A (he)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5256664A (en) * 1992-04-28 1993-10-26 Bristol-Myers Squibb Company Antidepressant 3-halophenylpiperazinylpropyl derivatives of substituted triazolones and triazoldiones
US5502047A (en) * 1993-03-22 1996-03-26 Kavey; Neil B. Treatment for insomnia
CA2187989A1 (en) 1995-10-17 1997-04-18 Ronald N. Marcus Nefazodone: treatment of panic attack
AU2452397A (en) * 1996-07-31 1998-02-20 Bristol-Myers Squibb Company Nefazodone: use in migraine prophylaxis
US5852020A (en) * 1996-11-22 1998-12-22 Bristol-Myers Squibb Company Nefazodone: use in treating post traumatic stress disorder
WO1998024411A2 (en) * 1996-12-04 1998-06-11 Bristol-Myers Squibb Company Method for oral administration of buspirone
PT1126853E (pt) * 1998-11-02 2006-07-31 Alza Corp Distribuicao controlada de anti-depressivos
US6465469B1 (en) 1999-04-09 2002-10-15 Sepracor Inc. S-hydroxynefazodone
US6469008B2 (en) 1999-04-09 2002-10-22 Sepracor Inc. (R)-hydroxynefazodone antipsychotic therapy
WO2000061128A2 (en) 1999-04-09 2000-10-19 Sepracor Inc. R-hydroxynefazodone
US6586437B2 (en) 1999-04-09 2003-07-01 Sepracor Inc. (S)-hydroxynefazodone antipsychotic therapy
CA2473586A1 (en) * 2002-01-18 2003-08-21 Hypnion, Inc. Treatment of sleep disorders using sleep target modulators
GB0306604D0 (en) * 2003-03-21 2003-04-30 Curidium Ltd Second medical use
PL1691811T3 (pl) * 2003-12-11 2014-12-31 Sunovion Pharmaceuticals Inc Skojarzenie leku uspokajającego i modulatora neuroprzekaźnikowego oraz sposoby poprawy jakości snu i leczenia depresji
EP1737473A4 (en) * 2004-04-19 2009-08-26 Noven Therapeutics Llc COMBINATIONS OF LITHIUM AND USES THEREOF
WO2007142810A2 (en) 2006-05-19 2007-12-13 Somaxon Pharmaceuticals, Inc. Methods of using low-dose doxepin for the improvement of sleep
US20080058408A1 (en) 2006-05-19 2008-03-06 Rogowski Roberta L Low-dose doxepin for treatment of sleep disorders in elderly patients
US20100179215A1 (en) 2006-05-19 2010-07-15 Somaxon Pharmaceuticals, Inc. Doxepin isomers and isomeric mixtures and methods of using the same to treat sleep disorders
US20100179214A1 (en) 2006-05-19 2010-07-15 Somaxon Pharmaceuticals, Inc. Doxepin trans isomers and isomeric mixtures and methods of using the same to treat sleep disorders
WO2007136741A2 (en) * 2006-05-19 2007-11-29 Somaxon Pharmaceuticals, Inc. N-desmethyl-doxepin and methods of using the same to treat sleep disorders
CA2693992C (en) 2006-07-20 2017-01-31 Somaxon Pharmaceuticals, Inc. Methods of improving the pharmacokinetics of doxepin
US20080182890A1 (en) * 2006-10-04 2008-07-31 Somaxon Pharmaceuticals, Inc. Methods of using low-dose doxepin for the improvement of sleep
WO2008052139A2 (en) 2006-10-25 2008-05-02 Somaxon Pharmaceuticals, Inc. Ultra low dose doxepin and methods of using the same to treat sleep disorders
WO2008070795A2 (en) * 2006-12-06 2008-06-12 Somaxon Pharmaceuticals, Inc. Combination therapy using low-dose doxepin for the improvement of sleep
CA2721133C (en) 2007-04-13 2018-11-06 Somaxon Pharmaceuticals, Inc. Low-dose doxepin formulations and methods of making and using the same
US9339500B2 (en) * 2008-03-04 2016-05-17 Intra-Cellular Therapies, Inc. Methods of treating vasomotor symptoms

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4338317A (en) * 1981-03-16 1982-07-06 Mead Johnson & Company Phenoxyethyl-1,2,4,-triazol-3-one antidepressants

Also Published As

Publication number Publication date
EP0493687B1 (en) 1996-04-17
EP0493687A2 (en) 1992-07-08
DK0493687T3 (da) 1996-05-13
IL100183A0 (en) 1992-08-18
DE69118859T2 (de) 1996-09-05
GR3019692T3 (en) 1996-07-31
ES2087217T3 (es) 1996-07-16
JP3062974B2 (ja) 2000-07-12
DE69118859D1 (de) 1996-05-23
JPH04300873A (ja) 1992-10-23
MX9101994A (es) 1992-06-01
US5116852A (en) 1992-05-26
EP0493687A3 (en) 1992-07-22
ATE136777T1 (de) 1996-05-15
CA2056201A1 (en) 1992-06-04

Similar Documents

Publication Publication Date Title
US5116852A (en) Treatment of sleep disorders
US5840331A (en) Use of γ-hydroxybutyrate for the stimulation of sleep-related secretion growth hormone and prolactin
EP0236684B1 (en) Galanthamine or analogues thereof for treating alzheimer's disease
CA2004239C (en) Use of acetyl d-carnitine in the therapeutic treatment of glaucoma, and pharmaceutical compositions useful in such treatment
HUT71889A (en) Pharmaceutical compositions containing terfenadine metabolites and their optically pure isomers for treating allergic disorders
DE69324466D1 (de) L-dopa Ester-enthaltende Zusammensetzung
US20100227916A1 (en) N-desmethyl-doxepin and methods of using the same to treat sleep disorders
EP0506658A1 (en) COMPOSITION AND METHOD FOR TREATING INFLAMMATORY OR ALLERGIC PAIN SYMPTOMS.
IE61612B1 (en) Antiparkinson ergoline derivatives
CA2238770A1 (en) Use of a combination of pentoxifylline and type i interferons for treating multiple sclerosis
EP0217258B1 (en) The use of choline or choline releasing compounds for reducing the perception of fatigue
US4686225A (en) Vinpocetine for pulmonary hemorrhage and edema
EP0694299A1 (en) The use of( a) bicycloheptane derivative(s)
US4829068A (en) Treatment of disorders of the gastro-intestinal tract
HUP0203790A2 (hu) (6-Metoxi-2-naftil)-ecetsav prodrugokat tartalmazó gyógyszerkészítmények alkalmazása gyulladás kezelésére
EP1011679B1 (en) Use of 8-nitro-2,3,4,5-tetrahydro-1h-3-benzazepines for the manufacture of a pharmaceutical composition for the treatment of sleep disorders
US6288112B1 (en) Use of pyrethroid compounds to promote hair growth
US4375473A (en) Method
US20030096805A1 (en) Antidepressants and their analogues as long-acting local anesthetics and analgesics
IT8247658A1 (it) Medicamenti a base di derivati condensati dell'imidazolo per il trattamento di disturbi urinari
US4156003A (en) Treatment of hypertension with combination of clofibrinic acid or clofibrate with cinnarizine
CA1209047A (en) Therapeutic composition containing piracetam analog
US5362731A (en) Use of piribedil derivatives and analogs for the treatment of hyperactive or unstable bladders
NZ225426A (en) Anti-arrhythmic pharmaceutical compositions, in unit dosage form, containing 4-amino-6,7-dimethoxy-2-(6,7-dimethoxy-1,2,3,4-tetrahydroisoquinol-2-yl)quinoline
KR920003580B1 (ko) 동맥경화증 예방 및 치료제

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees